RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > In Focus: Compliance in the Global Setting

In Focus: Compliance in the Global Setting

Posted 01 October 2011

By Mukesh Kumar, PhD, RAC
The last few years have seen the US Food and Drug Administration (FDA) become increasingly aggressive in monitoring the compliance status of the biopharmaceutical and medical device industries. Recently, the number of auditors in the Division of Scientific Investigations within the Office of Compliance was increased significantly to boost the number of inspections both domestically and internationally for all companies exporting regulated products to the US.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.